✦ LIBER ✦

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

✍ Scribed by Calabresi, Peter A; Radue, Ernst-Wilhelm; Goodin, Douglas; Jeffery, Douglas; Rammohan, Kottil W; Reder, Anthony T; Vollmer, Timothy; Agius, Mark A; Kappos, Ludwig; Stites, Tracy; Li, Bingbing; Cappiello, Linda; von Rosenstiel, Philipp; Lublin, Fred D

Book ID: 122443231
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 290 KB
Volume: 13
Category: Article
ISSN: 1474-4465
DOI: 10.1016/S1474-4422(14)70049-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of oral fumarate in

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

✍ Ludwig Kappos; Ralf Gold; David H Miller; David G MacManus; Eva Havrdova; Volker 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 209 KB

Oral teriflunomide for patients with rel

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

✍ Confavreux, Christian; O'Connor, Paul; Comi, Giancarlo; Freedman, Mark S; Miller 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 329 KB

Relapse and disability outcomes in patie

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

✍ Virginia Devonshire; Eva Havrdova; Ernst Wilhelm Radue; Paul O'Connor; Lixin Zha 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 212 KB

Effect of laquinimod on MRI-monitored di

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

✍ G Comi; A Pulizzi; M Rovaris; O Abramsky; T Arbizu; A Boiko; R Gold; E Havrdova; 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 143 KB

Efficacy of vitamin D3 as add-on therapy

Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

✍ Joost Smolders; Raymond Hupperts; Frederik Barkhof; Luigi M.E. Grimaldi; Trygve 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 355 KB

Glatiramer acetate in combination with m

Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial

✍ Metz, L.; Li, D.; Traboulsee, A.; Myles, M.; Duquette, P.; Godin, J.; Constantin 📂 Article 📅 2009 🏛 SAGE Publications 🌐 English ⚖ 317 KB